A recent study has brought encouraging news for those affected by Alzheimer’s disease. An older GLP-1 (glucagon-like peptide-1) drug developed…
Promising Results: Eli Lilly’s Experimental Drug Delays Alzheimer’s Progression
Alzheimer’s disease is a progressive brain disorder that affects memory, thinking, and behavior. It is the most common cause of…